M-MDSC activation and differentiation in tumor microenvironment. M-MDSC can differentiate into M1-like phenotype (controlled by TLR ligands, C5a, INFγ, IL-12, and IL-1β), which have antitumor effect through the production of iNOS. Alternatively, M-MDSC can differentiate into M2-like phenotype (controlled by IL-10, IL-6, TGF-β, IL-13, and IL-4), which promotes tumor growth, tissue remodeling and angiogenesis through producing IL-10 and arginase. In addition, the expansion of MDSC population can be controlled by VEGF, GM-CSF, G-CSF, M-CSF, SCF1, prostaglandins, S100A8/A9, and FLT3
Activation of M-MDSC by these factors leads to the signaling of
various pathways in differentiation of MDSC as summarized in
Fig. 3. .
Viewing this image requires a subscription. If you are a subscriber, please log in.
This image is from the article titled "Myeloid-derived suppressor cells in transplantation and cancer"
(from Immunologic Research), which is copyrighted by Springer Science+Business Media, LLC. For more information on the
copyright for this image, please refer to the full image caption and to the
The image is being made available for non-commercial purposes for subscribers to SpringerImages. For more information on what you are allowed to do with this image, please see our copyright policy.
To request permissions to use any copyrighted material, please visit the source document.
Report a copyright concern regarding this image.
Log in or register to save your favorite images and download them as high-quality PowerPoint or PDF files.
Log in or register to save your search criteria.
© Springer, part of Springer Science+Business Media.
Remote Address: 22.214.171.124 Server: 18